Plunkett Research Online: ASLAN Pharmaceuticals Ltd

ASLAN PHARMACEUTICALS LTD (ASLN:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

ASLAN Pharmaceuticals Ltd is a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. The company is engaged in the development of novel drugs for Asia prevalent cancers. Its portfolio includes ASLAN004, a monoclo.....



ASLAN Pharmaceuticals Ltd
Ticker: ASLN
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 65 62224235
Fax: 65 62252419
Address: 83 Clemenceau Avenue
No. 12-03 UE Square
Singapore, 239920 Singapore

Types Of Business
Industry Ranks

Industry NAICS code:

Biotechnology

Ranks not available
ContactsDescription

ASLAN Pharmaceuticals Ltd is a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. The company is engaged in the development of novel drugs for Asia prevalent cancers. Its portfolio includes ASLAN004, a monoclo.....See More See More

Auditor: Deloitte & Touche
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201920182017201620152014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: